ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79 | -32.5% | 24,801 | +5.4% | 0.00% | 0.0% |
| Q2 2023 | $117 | -11.4% | 23,521 | -11.8% | 0.00% | 0.0% |
| Q1 2023 | $132 | -18.5% | 26,655 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $162 | -99.9% | 25,790 | -8.3% | 0.00% | -50.0% |
| Q3 2022 | $304,000 | +112.6% | 28,115 | +123.6% | 0.00% | +100.0% |
| Q2 2022 | $143,000 | -2.1% | 12,572 | -21.5% | 0.00% | 0.0% |
| Q1 2022 | $146,000 | -34.2% | 16,022 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $222,000 | -30.6% | 14,898 | +19.6% | 0.00% | -50.0% |
| Q3 2021 | $320,000 | +56.9% | 12,460 | +59.4% | 0.00% | +100.0% |
| Q2 2021 | $204,000 | -12.1% | 7,815 | +18.8% | 0.00% | 0.0% |
| Q1 2021 | $232,000 | -72.4% | 6,580 | -70.5% | 0.00% | -80.0% |
| Q3 2020 | $840,000 | – | 22,284 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |